Valuation: Fresenius SE & Co. KGaA

Capitalization 2.8TCr 3.24TCr 2.6TCr 2.42TCr 4.51TCr 2,94300Cr 4.85TCr 30TCr 12TCr 1,40400Cr 12TCr 12TCr 5,12600Cr P/E ratio 2025 *
18.8x
P/E ratio 2026 * 14.7x
Enterprise value 3.91TCr 4.53TCr 3.64TCr 3.39TCr 6.3TCr 4,11100Cr 6.78TCr 42TCr 16TCr 1,96100Cr 17TCr 17TCr 7,16100Cr EV / Sales 2025 *
1.73x
EV / Sales 2026 * 1.61x
Free-Float
73.04%
Yield 2025 *
2.21%
Yield 2026 * 2.38%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.18%
1 week+1.22%
Current month+1.74%
1 month+5.06%
3 months+5.55%
6 months+21.71%
Current year+1.74%
More quotes
1 week 49.14
Extreme 49.14
51.98
1 month 47.38
Extreme 47.38
51.98
Current year 47.47
Extreme 47.47
51.98
1 year 31.6
Extreme 31.6
51.98
3 years 23.29
Extreme 23.29
51.98
5 years 19.69
Extreme 19.69
51.98
10 years 19.69
Extreme 19.69
80.07
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 01/10/2022
Director of Finance/CFO 46 01/09/2022
Compliance Officer 50 -
Director TitleAgeSince
Director/Board Member 71 20/05/2015
Director/Board Member 65 13/05/2016
Director/Board Member 52 01/01/2008
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.36%+1.22%+39.97%+74.54% 3.25TCr
-2.37%+0.00%+52.56%+82.75% 11TCr
-2.52%-1.50%+52.23%-11.50% 10TCr
-0.46%+4.73%-13.25%+16.86% 2.42TCr
+0.90%+7.47%+13.34%+6.23% 2.23TCr
+0.26%+9.13%+25.52%+29.02% 2.12TCr
-2.77%-2.82%+47.27%+268.58% 1.77TCr
-0.89%-3.01%+49.68%+52.89% 1.66TCr
-2.22%-3.71%+8.30%+36.02% 1.28TCr
+1.46%-5.14%-16.40%+10.40% 1.2TCr
Average -0.80%+0.87%+25.92%+56.58% 3.73TCr
Weighted average by Cap. -1.54%+1.22%+39.11%+47.59%
See all sector performances

Financials

2025 *2026 *
Net sales 2.25TCr 2.62TCr 2.1TCr 1.95TCr 3.64TCr 2,37300Cr 3.91TCr 24TCr 9.52TCr 1,13200Cr 9.81TCr 9.61TCr 4,13300Cr 2.38TCr 2.75TCr 2.21TCr 2.06TCr 3.83TCr 2,50000Cr 4.12TCr 25TCr 10TCr 1,19200Cr 10TCr 10TCr 4,35400Cr
Net income 153Cr 177.47Cr 142.43Cr 132.6Cr 246.88Cr 16TCr 265.62Cr 1.64TCr 646.01Cr 7.68TCr 665.53Cr 651.83Cr 28TCr 191.65Cr 222.31Cr 178.41Cr 166.09Cr 309.25Cr 20TCr 332.73Cr 2.05TCr 809.22Cr 9.62TCr 833.67Cr 816.51Cr 35TCr
Net Debt 1.11TCr 1.29TCr 1.03TCr 961.9Cr 1.79TCr 1,16800Cr 1.93TCr 12TCr 4.69TCr 56TCr 4.83TCr 4.73TCr 2,03500Cr 1.03TCr 1.19TCr 958.2Cr 892.05Cr 1.66TCr 1,08300Cr 1.79TCr 11TCr 4.35TCr 52TCr 4.48TCr 4.39TCr 1,88700Cr
More financial data * Estimated data
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (39.1%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. ; - other (1.7%).
Employees
1,77,356
More about the company
Date Price Change Volume
16/26/16 49.83 +0.36% 6,89,700
15/26/15 49.65 -4.48% 15,35,022
14/26/14 51.98 +1.44% 16,99,429
13/26/13 51.24 +1.03% 8,68,292
12/26/12 50.72 +3.03% 9,22,918

Delayed Quote Xetra, January 16, 2026 at 10:08 pm IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
49.65EUR
Average target price
55.26EUR
Spread / Average Target
+11.29%
Consensus

Quarterly revenue - Rate of surprise